In a report released today, David Westenberg from Piper Sandler reiterated a Hold rating on Quest Diagnostics (DGX – Research Report), with a ...
Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...
Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...
Quest Diagnostics Inc.’s DGX fourth-quarter 2024 adjusted earnings per share (EPS) of $2.23 beat the Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback